Ingavirin forte for flu and other viral infections
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests different doses of Ingavirin Forte capsules for treating influenza and other respiratory viruses. It may help people with fever, cough, sore throat, and body aches who have been sick less than 48 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old.
- You must have flu or another respiratory virus confirmed by a PCR test.
- You must have a fever above 100.4°F (38°C) and at least two symptoms like cough, runny nose, sore throat, or throat irritation that are moderate to severe.
- Your symptoms must have started no more than 48 hours before you take the first dose.
- You cannot be pregnant, breastfeeding, or have certain health conditions like severe obesity, diabetes, chronic lung disease, or a weak immune system.
- You must agree to use effective birth control during the study and for 30 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This trial tests how safe and tolerable different doses of Ingavirin Forte are in healthy people. It helps find the right dose for future studies.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This trial studies whether Apomivir works and is safe for people who likely have the flu and test positive for influenza A or B. You may help researchers learn if treating early can reduce flu illness and side effects.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.